<DOC>
	<DOCNO>NCT02182076</DOCNO>
	<brief_summary>Study assess pharmacokinetics extend absorption single dose BIBF 1120 soft gelatine capsule food effect ( BA ) healthy subject respectively .</brief_summary>
	<brief_title>Pharmacokinetics/Bioavailability BIBF 1120 Administered Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Nintedanib</mesh_term>
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance GCP ( Good Clinical Practice ) local legislation Age ≥21 ≤55 year Body Mass Index ≥18.5 kg/m2 ≤29.9 kg/m2 Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance History current gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hormonal disorder History orthostatic hypotension , faint spell blackouts Diseases central nervous system ( epilepsy ) psychiatric disorder Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator History bleed disorder include prolonged habitual bleeding , hematologic disease cerebral bleeding ( e.g . car accident ) commotio cerebri Intake drug long halflife ( &gt; 24 hour ) within 1 month prior administration Use drug might influence result trial within 10 day prior administration trial Participation another trial investigational drug within 2 month prior administration trial Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) inability refrain smoke study day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation within 1 month prior administration trial Excessive physical activity within 5 day prior administration trial Any laboratory value outside clinically accept reference range Female gender Male subject must agree minimize risk female partner become pregnant first dose day 3 month completion study . Acceptable method contraception male volunteer include vasectomy less 3 month prior dose , barrier contraception medically accept contraceptive method . For female partner male volunteer , acceptable method contraception include intrauterine device , tubal ligation , hormonal contraceptive since least two month diaphragm spermicide</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>